Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.404
+0.022 (5.78%)
Nov 8, 2024, 12:31 PM EST - Market open

Citius Pharmaceuticals Stock Forecast

CTXR's stock price has decreased by -50.36% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for CTXR stock have an average target of 5.00, with a low estimate of 4.00 and a high estimate of 6.00. The average target predicts an increase of 1,136.71% from the current stock price of 0.40.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $4.00 $5.00 $6.00 $6.00
Change +889.36% +1136.7% +1384.0% +1384.0%
* Price targets were last updated on Aug 19, 2024.

Analyst Ratings

The average analyst rating for CTXR stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 112222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 112222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
EF Hutton
EF Hutton
Strong Buy
Maintains
$6
Strong Buy Maintains $6 +1,384.05% Aug 19, 2024
EF Hutton
EF Hutton
Strong Buy
Maintains
$6
Strong Buy Maintains $6 +1,384.05% Aug 8, 2024
EF Hutton
EF Hutton
Strong Buy
Maintains
$6
Strong Buy Maintains $6 +1,384.05% Aug 5, 2024
EF Hutton
EF Hutton
Strong Buy
Initiates
$6
Strong Buy Initiates $6 +1,384.05% Jul 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +889.36% May 31, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
88.16M
EPS This Year
-0.20
from -0.22
EPS Next Year
0.19
from -0.20
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Sep 30, 2019 Sep 30, 2020 Sep 30, 2021 Sep 30, 2022 Sep 30, 2023 Sep 30, 2024 Sep 30, 2025 Sep 30, 2026
Revenue
------88.16M242.39M
Revenue Growth
-------174.95%
EPS
-0.77-0.45-0.23-0.23-0.22-0.200.190.78
EPS Growth
-------300.00%
Forward PE
------2.090.52
No. Analysts -----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High n/a 127.4M 289.0M
Avg n/a 88.2M 242.4M
Low n/a 45.0M 196.0M

Revenue Growth

Revenue Growth 202420252026202720282029
High - -
227.9%
Avg - -
175.0%
Low - -
122.3%

EPS Forecast

EPS 202420252026
High -0.21 0.20 0.80
Avg -0.20 0.19 0.78
Low -0.20 0.19 0.74

EPS Growth

EPS Growth 202420252026
High - -
311.8%
Avg - -
300.0%
Low - -
284.3%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.